SEARCH   
MEMBER LOGIN    

Pain Medication OTC Manufacturing in Australia: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Pain Medication OTC Manufacturing Market Research Report | Life Sciences | OTC Medicines | May 2013

Growth pains: Competition from manufacturers abroad hampers industry revenue

IBISWorld’s Pain Medication OTC Manufacturing market research report is a comprehensive guide to market size and growth prospects. Our industry reports offer strategic industry analysis of the factors influencing companies, including new product developments, economic, lifestyle and demographic influences, distribution and supply chain factors and pricing issues. Full analysis accompanies our data forecasts to illustrate how the market responds to emerging industry trends.

Report Snapshot
Market Share of Companies
GlaxoSmithKline GlaxoSmithKline market share
Pfizer Australia Pfizer Australia market share
Industry Statistics & Market Size
Revenue
$834m
Annual Growth 08-13
-2.0%
Annual Growth 13-18
Purchase to read more
Profit
Purchase to read more
Employment
1,814
Businesses
87
Industry Analysis & Industry Trends

The Pain Medication OTC Manufacturing industry manufactures pharmaceutical products that focus on pain relief and are available without a doctor's permission. As a country with a high awareness of medication and self-medication uses, domestic demand for OTC pain medication has remained healthy over the past five years. This is despite a cautious consumer environment in which consumers have attempted to focus spending on high-value items.

Local manufacturing operations have struggled to benefit from this trend. Global pharmaceutical manufacturing has shifted production towards Asia, where labour is cheaper and the plants are larger, leading to substantial increases in economies of scale. With these jumps in production capacity, import competition has increased substantially... purchase to read more

Industry Report - Industry SWOT Analysis Chapter

The Pain Medication OTC Manufacturing industry is expected to be in the mature phase of its life cycle. The industry grew strongly in the early 1980s. Over the last five years, industry revenue has been significantly hampered by rising competition from generic drugs, increasing import penetration and falling branded drug prices due to government policy. The industry's contribution to the overall economy has fallen, with Industry value added expected to fall at an annualised rate of 1.0% over the 10 years through 2017-18. The Australian GDP is expected to grow at an annualised 2.4% over the same period.

The number of enterprises has dropped, which is also a testament to the industry's mature life cycle... purchase to read more

 


Industry ProductsRelated ReportsTable of Contents

What is the Pain Medication OTC Manufacturing Industry?

Companies in this industry research and develop medicines with pain-relieving, anti-inflammatory and other effects. Products manufactured by the industry are available without a prescription in various OTC locations.

Industry Products
SalicylatesPropionic acid derivativesAcetaminophensOther non-steroidal anti-inflammatory drugs
 
Industry Activities
Manufacturing acetaminophen based pain suppressantsManufacturing non-steroidal anti-inflammatory based pain suppressantsManufacturing acetaminophen based pain suppressantsManufacturing non-steroidal anti-inflammatory based pain suppressants


View Sample
Quote
Select Clients